SOURCE: ProActive Capital

ProActive Capital

September 04, 2013 11:48 ET

ProActive Capital Group Announces Roster of Clients Presenting at Rodman & Renshaw Annual Global Investment Conference

Ten Life Science Clients to Present on September 9th and 10th

NEW YORK, NY--(Marketwired - Sep 4, 2013) - ProActive Capital Group, a leading capital markets advisory and media strategies firm, today announced a client roster of ten presenting companies at the 2013 Rodman & Renshaw Annual Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference will be held at The Millennium Broadway Hotel in New York City on September 9th and 10th, 2013.

More than 200 public & private companies from around the world are expected to present to an audience of over 1,500 attendees. The conference will feature tracks devoted to Biotechnology/Healthcare, Technology, Natural Resources, and Growth. The Conference will include corporate presentations and Q & A sessions, investor one-on-one meetings and daily networking opportunities.

To visit the conference website, CLICK HERE, or use the following address:

To listen to a webcast of the clients who have selected the service, CLICK HERE, or use the following address:

In addition, if you are interested in speaking with any of these companies, please contact Adam Holdsworth or Jared Mitchell at ProActive Capital Group - 646-862-4607.

These companies will provide an overview of each of their businesses during a live presentation and will be available to participate in one-on-one meetings with investors who are registered to attend the conference. The list of Proactive Capital's clients include:

  • NeoStem, Inc. (NBS): A leader in the emerging cellular therapy industry
    Presenting at 10:50 am on Monday the 9th in room 701 - 7th Floor

  • Prima BioMed (PBMD): A leader in the development of personalized bio-therapeutic products for cancer
    Presenting at 11:15 am on Monday the 9th in room 701 - 7th Floor

  • Targeted Medical Pharma (TRGM): A biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies
    Presenting at 11:40 am on Monday the 9th in room 702 - 7th floor

  • Soligenix (SNGX): A clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need
    Presenting at 11:40 am on Monday the 9th in room 703 - 7th floor

  • Atheronova (AHRO): A biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans
    Presenting at 12:05 pm on Monday the 9th in room 703 - 7th floor

  • Stem Cell Therapeutics Corp (SCTPF): A biopharmaceutical company developing cancer stem cell-related therapeutics
    Presenting at 2:50 pm on Monday the 9th in room 701 - 7th floor

  • LabStyle Innovations Corp (DRIO): Developer of the Dario™ smartphone-based glucose monitor and diabetes data-management system
    Presenting at 9:10 am on Tuesday the 10th in room 701 - 7th floor

  • Inovio Pharmaceuticals (INO): Revolutionizing vaccines to prevent and treat today's cancers and challenging infectious diseases
    Presenting at 11:15am on Tuesday the 10th in room 702 - 7th floor

  • Protea BioSciences Group: A leader in the emerging field of Bioanalytics
    Presenting at 9:10am on Tuesday the 10th in room 702 - 7th floor

  • VolitionRX Ltd (VNRX): A life sciences company focused on the development of blood-based diagnostic tests
    Presenting at 2:25pm on Tuesday the 10th in room 703 - 7th floor

Follow the official Rodman & Renshaw handle on Twitter @Rodman_2013 and use #Rodman2013 for conference information and updates. 

About ProActive Capital Group
ProActive Capital Group is dedicated to the discovery and creation of value specifically in the emerging public company marketplace. The Company provides unique solutions that combine capital markets advisory and strategic communications. PCG's overarching goal is to develop and leverage stakeholder awareness from all key constituents in order to maximize shareholder value. PCG's capital markets advisory services include overall investor strategy development to increase and leverage awareness, visibility & credibility. The Company's strategic communications services leverage traditional, digital and social media channels to further increase awareness to all key constituents. Communicating the client's story accurately and effectively to a wide but concentrated audience is tantamount to maximizing exposure to its current and potential stakeholders. For additional information:

About Rodman & Renshaw Conferences, LLC

The Rodman & Renshaw Annual Global Investment Conference is an informational service and networking opportunity for companies and investors. Rodman does not prepare, review or edit the presentations and other information provided by each company, and does not take any responsibility for the accuracy or adequacy of any such information as the basis for any investment decision. Rodman is not providing any person with any investment advice through their participation in or attendance of the Conference, nor is Rodman soliciting any offers to buy or sell any security of any company.

Contact Information